Literature DB >> 25150002

Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression.

Ewa A Ogłodek1, Anna Szota2, Marek J Just3, Danuta Moś4, Aleksander Araszkiewicz2.   

Abstract

BACKGROUND: Depression can be perceived as a psychoneuroimmunological disorder in which cytokines affecting the body's neurochemical and neuroendocrine functions play an important role. Among cytokines, chemokines participating in activation of the inflammatory response are considered to be crucial.
METHODS: 160 men and women were enrolled in the study. 120 of them were diagnosed with various types of depression. The mean age was 45.2 ± 4.5 years (range: 19-47 years). The control group consisted of 40 healthy individuals. The average age in this group was 42.4 ± 4.1 years. Plasma levels of chemokines and their receptors (CCL-5 - RANTES and CXCR-5, SDF-1 and CXCR-4), as well as of IL-6, were assessed by ELISA.
RESULTS: There was an increase in SDF-1 and CCL-5 levels in women and men with different severities of depression, versus the control group. Also, an increase in the IL-6 levels, CXCR4 and CCR-5 receptors was observed in both women and men with all types of depression. Levels of SDF-1 and CCL-5 chemokines, as well as of CCR-5 and CXCR4 chemokine receptors, were higher in women than in men.
CONCLUSIONS: The results of this study indicate the need for assessment of CCL-5 and SDF-1 chemokines levels, as they are likely markers of developing depression. Early measurement of these chemokines levels may be helpful in choosing the best pharmacotherapy.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Chemokine; Chemokine receptors; Depression

Mesh:

Substances:

Year:  2014        PMID: 25150002     DOI: 10.1016/j.pharep.2014.06.001

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  17 in total

1.  The association of dietary inflammatory potential with depression and mental well-being among U.S. adults.

Authors:  Rachel S Bergmans; Kristen M Malecki
Journal:  Prev Med       Date:  2017-03-22       Impact factor: 4.018

2.  Chemokine (C-C motif) ligand 5 (RANTES) concentrations in the peripheral blood of patients with a depressive disorder.

Authors:  Elżbieta Małujło-Balcerska; Anna Kumor-Kisielewska; Janusz Szemraj; Tadeusz Pietras
Journal:  Pharmacol Rep       Date:  2022-03-16       Impact factor: 3.919

3.  Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment.

Authors:  Olivia Bauer; Vladimir M Milenkovic; Sven Hilbert; Nina Sarubin; Johannes Weigl; Lisa-Marie Bahr; Thomas C Wetter; Barbara Heckel; Christian H Wetzel; Rainer Rupprecht; Caroline Nothdurfter
Journal:  Neuroimmunomodulation       Date:  2021-01-27       Impact factor: 2.492

Review 4.  The influence of atypical antipsychotic drugs on sexual function.

Authors:  Marek J Just
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-08       Impact factor: 2.570

5.  Saliva secretion disorder in a schizophrenic patient - a problem in dental and psychiatric treatment: a case report.

Authors:  Danuta Maria Moś
Journal:  Ann Gen Psychiatry       Date:  2015-03-10       Impact factor: 3.455

Review 6.  A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders.

Authors:  Joanna Ślusarczyk; Ewa Trojan; Jakub Chwastek; Katarzyna Głombik; Agnieszka Basta-Kaim
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

7.  Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity.

Authors:  Nuria García-Marchena; Pedro Fernando Araos; Vicente Barrios; Laura Sánchez-Marín; Julie A Chowen; María Pedraz; Estela Castilla-Ortega; Pablo Romero-Sanchiz; Guillermo Ponce; Ana L Gavito; Juan Decara; Daniel Silva; Marta Torrens; Jesús Argente; Gabriel Rubio; Antonia Serrano; Fernando Rodríguez de Fonseca; Francisco Javier Pavón
Journal:  Front Psychiatry       Date:  2017-01-18       Impact factor: 4.157

8.  Multiplex Immunoassay of Plasma Cytokine Levels in Men with Alcoholism and the Relationship to Psychiatric Assessments.

Authors:  Ann M Manzardo; Albert B Poje; Elizabeth C Penick; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2016-03-29       Impact factor: 5.923

9.  Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder.

Authors:  Damla Tokac; Erdem Tuzun; Huseyin Gulec; Vuslat Yılmaz; Elif Sinem Bireller; Bedia Cakmakoglu; Cem Ismail Kucukali
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

Review 10.  Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.

Authors:  S P Leighton; L Nerurkar; R Krishnadas; C Johnman; G J Graham; J Cavanagh
Journal:  Mol Psychiatry       Date:  2017-11-14       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.